FDA OKs Talquetamab, a First-in-Class Multiple Myeloma Drug FDA OKs Talquetamab, a First-in-Class Multiple Myeloma Drug

The approval follows a series of market withdrawals for other multiple myeloma drugs that initially received accelerated FDA approval.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news